Hepatitis C virus antibodies among risk groups in Turkey.
In order to determine the prevalence of hepatitis C virus (HCV) infection in the Black Sea region in Turkey, 287 serum samples taken from risk groups were investigated for anti-HCV antibodies using HCV EIA system. Anti-HCV antibodies were found to be positive in 51.2% of chronic haemodialysis patients, 20.6% of probable acute non-A, non-B hepatitis patients, 4% of patients who had multiple blood transfusions, 1.5% of the health personnel, while in new haemodialysis patients anti-HCV antibodies were not found.
Dept. of Infectious Disease, Black Sea Technical University School of Medicine, Trabzon, Turkey.
I
I
Köksal
K
K
Biberoğlu
S
S
Biberoğlu
F
F
Koç
Y
Y
Ayma
F
F
Aker
H
H
Köksal
D006282:Health Personnel; D006508:Hepatitis Antibodies / Q000097:blood*; D006526:Hepatitis C / Q000097:blood / Q000453:epidemiology* / Q000276:immunology; D006801:Humans; D015995:Prevalence; D006435:Renal Dialysis / Q000009:adverse effects; D012307:Risk Factors; D016036:Seroepidemiologic Studies; D065227:Transfusion Reaction; D014421:Turkey / Q000453:epidemiology
D006508:Hepatitis Antibodies